Does multiple sclerosis increase the risk of preeclampsia? A systematic review and meta-analysis

Does multiple sclerosis increase the risk of preeclampsia? A systematic review and meta-analysis

Objective: We investigated, via systematic review and meta-analysis, whether multiple sclerosis (MS) is associated with the risk of preeclampsia (PE). Methods: From the eligible studies, we pooled odds ratios (ORs) and confidence intervals (CIs) of PE for pregnant women with MS compared with pregnan...

Bibliografske podrobnosti
Main Authors:	Ahmed Arafa, Xiaowen Wang, Jia-Yi Dong, Ehab S Eshak
Format:	Article
Jezik:	English
Izdano:	Taylor & Francis Group 2021-07-01
Serija:	Hypertension in Pregnancy
Teme:	meta-analysis multiple sclerosis preeclampsia systematic review
Online dostop:	http://dx.doi.org/10.1080/10641955.2021.1921792

Podobne knjige/članki

The association between antenatal coffee consumption and preeclampsia: a systematic review and meta-analysis
od: Ahmed Arafa, et al.
Izdano: (2024-09-01)

The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis
od: Naeim Ehtesham, et al.
Izdano: (2021-06-01)

Global prevalence of fatigue in patients with multiple sclerosis: a systematic review and meta-analysis
od: Xiaodong Yi, et al.
Izdano: (2024-10-01)

Prevalence of Preeclampsia and Eclampsia in Iran: An Updated Systematic Review and Meta-Analysis
od: Sedigheh Abdollahpour, et al.
Izdano: (2024-09-01)

Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis
od: Yangxue Yin, et al.
Izdano: (2023-10-01)

Pravastatin in preeclampsia: A meta-analysis and systematic review
od: Balázs Mészáros, et al.
Izdano: (2023-01-01)

The epidemiology of primary headaches in patients with multiple sclerosis
od: Long Wang, et al.
Izdano: (2021-01-01)

Safety and Efficacy of Fingolimod Compared to Placebo in the Treatment of Relapsing Multiple Sclerosis: A Systematic Review and Meta-analysis Study
od: Hamidreza Dehghan, et al.
Izdano: (2021-02-01)

Aspirin for the prevention of preeclampsia: A systematic review and meta-analysis of randomized controlled studies
od: Yixiao Wang, et al.
Izdano: (2022-11-01)

Glycosylated fibronectin in preeclampsia: a systematic review and meta-analysis
od: Lingyun Liao, et al.
Izdano: (2025-02-01)

Association between Tumor Necrosis Factor- α-308 G/A Polymorphism and Multiple Sclerosis: A Systematic Review and Meta-Analysis
od: Hamidreza Tolide-ie, et al.
Izdano: (2014-01-01)

Effects of calcium supplementation on the prevention of preeclampsia: an umbrella review of systematic reviews and meta-analyses
od: Henok Kumsa, et al.
Izdano: (2025-03-01)

Effects of mindfulness-based interventions on cognition in people with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials
od: Alyssa Komar, et al.
Izdano: (2024-07-01)

Impact of menopause on relapse rate and disability level in patients with multiple sclerosis (MS): a systematic review and meta-analysis
od: Zahra Shahraki, et al.
Izdano: (2023-09-01)

Effect of Mediterranean diet on body mass index and fatigue severity in patients with multiple sclerosis: A systematic review and meta-analysis of clinical trials
od: Amir Reza Moravejolahkami, et al.
Izdano: (2024-09-01)

Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients
od: Zhile Bai, et al.
Izdano: (2019-10-01)

Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis
od: Eduardo Carvalho de Arruda Veiga, et al.

Assisted reproductive technology and the risk of preeclampsia: an updated systematic review and meta-analysis
od: Amir Almasi-Hashiani, et al.
Izdano: (2019-05-01)

Prevalence of cognitive impairment (CI) in patients with multiple sclerosis (MS): a systematic review and meta-analysis
od: Mozhde Askari, et al.
Izdano: (2024-05-01)

Efficacy of vitamin D supplementation on the incidence of preeclampsia: a systematic review and meta-analysis
od: Khaled Moghib, et al.
Izdano: (2024-12-01)

Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis
od: Katelijn M. Blok, et al.
Izdano: (2023-11-01)

Diagnostic efficacy of long non-coding RNAs in multiple sclerosis: a systematic review and meta-analysis
od: Yongdong Wang, et al.
Izdano: (2024-05-01)

The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses
od: Suzi B. Claflin, et al.
Izdano: (2019-01-01)

The relationship between cadmium exposure and preeclampsia: a systematic review and meta-analysis
od: Chu Li, et al.
Izdano: (2023-12-01)

Risk of cancer development associated with disease-modifying therapies for multiple sclerosis: study protocol for a systematic review and meta-analysis of randomised and non-randomised studies
od: Ferrán Catalá-López, et al.
Izdano: (2024-10-01)

How does the brain age in individuals with multiple sclerosis? A systematic review
od: Nataliya Tokarska, et al.
Izdano: (2023-06-01)

Quantitative susceptibility mapping in multiple sclerosis: A systematic review and meta-analysis
od: Cui Ci Voon, et al.
Izdano: (2024-01-01)

The most effective sexual function and dysfunction interventions in individuals with multiple sclerosis: A systematic review and meta-analysis
od: Bahare Afshar, et al.
Izdano: (2022-04-01)

Which experimental factors govern successful animal-to-human translation in multiple sclerosis drug development? A systematic review and meta-analysisResearch in context
od: Ingrid Berg, et al.
Izdano: (2024-12-01)

Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol
od: Thomas Lehnert, et al.
Izdano: (2022-07-01)

Association between intrahepatic cholestasis of pregnancy and risk of gestational diabetes and preeclampsia: a systematic review and meta-analysis
od: Ahmed Arafa, et al.
Izdano: (2020-07-01)

Effectiveness of Non-Pharmacological Interventions for Spasticity Management in Multiple Sclerosis: A Systematic Review
od: Bhasker Amatya, et al.
Izdano: (2024-10-01)

Sleep and cognitive outcomes in multiple sclerosis; a systematic review
od: Behnam Golabi, et al.
Izdano: (2024-09-01)

Stigma and health outcomes in multiple sclerosis: a systematic review
od: Bradley Powell, et al.
Izdano: (2024-09-01)

Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis
od: Imtiaz A Samjoo, et al.
Izdano: (2023-06-01)

Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials
od: Enyao Zhang, et al.
Izdano: (2021-02-01)

Effect of Vitamin D supplements on relapse rate and Expanded Disability Status Scale (EDSS) in multiple sclerosis (MS): A systematic review and meta-analysis
od: Sara Hanaei, et al.
Izdano: (2021-01-01)

The Association Between ABO Blood Group and Preeclampsia: A Systematic Review and Meta-Analysis
od: Ting Li, et al.
Izdano: (2021-06-01)

Pharmacogenomics of Multiple Sclerosis: A Systematic Review
od: Keli Hočevar, et al.
Izdano: (2019-02-01)

Anti-Müllerian Hormone Levels in Preeclampsia: A Systematic Review of the Literature
od: Vasilios Pergialiotis, et al.
Izdano: (2018-06-01)